Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey M Craft

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Future Medicinal Chemistry|June 8, 2011
Towards novel radiosensitizing agents: the role of cytosolic PLA2α in combined modality cancer therapyJeffrey M Craft, Dennis Hallahan
Expert Opinion on Therapeutic Targets|September 28, 2005
Neuroinflammation: a potential therapeutic targetJeffrey M Craft, D Martin Watterson, Linda J Van Eldik
Glia|December 22, 2005
Human amyloid beta-induced neuroinflammation is an early event in neurodegenerationJeffrey M Craft, D Martin Watterson, Linda J Van Eldik
Journal of Neuroinflammation|June 22, 2005
Interleukin 1 receptor antagonist knockout mice show enhanced microglial activation and neuronal damage induced by intracerebroventricular infusion of human beta-amyloidJeffrey M Craft, D Martin Watterson, Emmet Hirsch, et al.
Glia|April 6, 2005
Enhanced susceptibility of S-100B transgenic mice to neuroinflammation and neuronal dysfunction induced by intracerebroventricular infusion of human beta-amyloidJeffrey M Craft, D Martin Watterson, Alexander Marks, et al.
Neurobiology of Aging|October 7, 2004
Aminopyridazines inhibit beta-amyloid-induced glial activation and neuronal damage in vivoJeffrey M Craft, D Martin Watterson, Sally A Frautschy, et al.
Journal of Molecular Neuroscience : MN|August 18, 2004
Aminopyridazines attenuate hippocampus-dependent behavioral deficits induced by human beta-amyloid in a murine model of neuroinflammationJeffrey M Craft, Linda J Van Eldik, Magdalena Zasadzki, et al.
Current Alzheimer Research|June 25, 2005
Validation of the neuroinflammation cycle as a drug discovery target using integrative chemical biology and lead compound development with an Alzheimer's disease-related mouse modelWenhui Hu, Hantamalala Ralay Ranaivo, Jeffrey M Craft, et al.
Journal of Proteome Research|January 14, 2011
A bioinformatics approach for biomarker identification in radiation-induced lung inflammation from limited proteomics dataJung Hun Oh, Jeffrey M Craft, Reid Townsend, et al.
Journal of Molecular Neuroscience : MN|September 23, 2003
Discovery of a new class of synthetic protein kinase inhibitors that suppress selective aspects of glial activation and protect against beta-amyloid induced injury: a foundation for future medicinal chemistry efforts focused on targeting Alzheimer's disease progressionD Martin Watterson, Anastasia V Velentza, Magdalena Zasadzki, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Future Medicinal Chemistry|June 8, 2011
Towards novel radiosensitizing agents: the role of cytosolic PLA2α in combined modality cancer therapyJeffrey M Craft, Dennis Hallahan
Expert Opinion on Therapeutic Targets|September 28, 2005
Neuroinflammation: a potential therapeutic targetJeffrey M Craft, D Martin Watterson, Linda J Van Eldik
Glia|December 22, 2005
Human amyloid beta-induced neuroinflammation is an early event in neurodegenerationJeffrey M Craft, D Martin Watterson, Linda J Van Eldik
Journal of Neuroinflammation|June 22, 2005
Interleukin 1 receptor antagonist knockout mice show enhanced microglial activation and neuronal damage induced by intracerebroventricular infusion of human beta-amyloidJeffrey M Craft, D Martin Watterson, Emmet Hirsch, et al.
Glia|April 6, 2005
Enhanced susceptibility of S-100B transgenic mice to neuroinflammation and neuronal dysfunction induced by intracerebroventricular infusion of human beta-amyloidJeffrey M Craft, D Martin Watterson, Alexander Marks, et al.
Neurobiology of Aging|October 7, 2004
Aminopyridazines inhibit beta-amyloid-induced glial activation and neuronal damage in vivoJeffrey M Craft, D Martin Watterson, Sally A Frautschy, et al.
Journal of Molecular Neuroscience : MN|August 18, 2004
Aminopyridazines attenuate hippocampus-dependent behavioral deficits induced by human beta-amyloid in a murine model of neuroinflammationJeffrey M Craft, Linda J Van Eldik, Magdalena Zasadzki, et al.
Current Alzheimer Research|June 25, 2005
Validation of the neuroinflammation cycle as a drug discovery target using integrative chemical biology and lead compound development with an Alzheimer's disease-related mouse modelWenhui Hu, Hantamalala Ralay Ranaivo, Jeffrey M Craft, et al.
Journal of Proteome Research|January 14, 2011
A bioinformatics approach for biomarker identification in radiation-induced lung inflammation from limited proteomics dataJung Hun Oh, Jeffrey M Craft, Reid Townsend, et al.
Journal of Molecular Neuroscience : MN|September 23, 2003
Discovery of a new class of synthetic protein kinase inhibitors that suppress selective aspects of glial activation and protect against beta-amyloid induced injury: a foundation for future medicinal chemistry efforts focused on targeting Alzheimer's disease progressionD Martin Watterson, Anastasia V Velentza, Magdalena Zasadzki, et al.
Pageof 2